Join our community

We offer a range of high-quality research degree programmes. Read more

Research facilities

From internationally significant archives to state-of-the-art laboratories. Read more

Research quality

Important, original research with high standards of scientific rigour and integrity. Find out more

Making a difference

How our research is benefiting society, culture and the economy. Find out more

Research showcase

A forward-looking University with an innovative, enterprising research culture. Find out more

Go back to the previous slide
Go to the next slide
The Kingston Business School research suggests that being a workaholic doesn't make people happier out of the office.

Professor scrutinises link between job and life satisfaction

According to new research long hours in the office can't make up for unhappiness at home. Read more


The Kingston Business School research suggests that being a workaholic doesn't make people happier out of the office.

The REF is the new system for assessing the quality of research in UK higher education institutions.

Dr Silvia Gullino and Dr Heidi Seetzen

Dr Silvia Gullino and Dr Heidi Seetzen

Handmade spaces: an exploration of built space, practices, memory and affect in a South London former squatting community

Cross-faculty research conducted by two Kingston lecturers may have uncovered a positive side to squatting communities. Dr Silvia Gullino and Dr Heidi Seetzen looked at how humans' attachment to space plays an integral part in shaping the places we live.

Research bites

Predicting  protein-protein interactions video image
Predicting protein-protein interactions

Predicting protein-protein interactions

PhD student Reyhaneh Esmaielbeiki is developing computational frameworks that can predict protein-protein interactions (PPIs). The interaction of proteins with other proteins, DNA, RNA and small molecules is essential for the functionality of living cells. Modifications in PPIs affect the events that take place within cells which may lead to critical diseases such as cancer. Therefore, knowledge about protein interactions can provide key information for drug design. Since experimental methods are costly and have limitations, Reyhaneh is developing a novel computational framework able to predict these interactions. Read more.